Overview

Drug Eluting Stents Market is predicted to value over USD xx billion by 2027 end with a CAGR of over xx% during the forecast period 2020 to 2027.

Rising geriatric population, unhealthy food habits, sedentary lifestyle and a lack of exercise are some of the key factors driving the drug eluting stents market growth. Additionally, the drastic shift to DES from angioplasty for treating atherosclerosis across the world has significantly boosted the market growth. Furthermore, the DS technique is minimally invasive which shall propel the proliferation of the market. On the other hand, the risks in implementing DES technique such as endothelial tissues regrowth disruption and stent thrombosis shall restrain the proliferation of the market.

Drug Eluting Stents Market

Market Segmentation:

By Product
•   Polymer-Based Coating
•   Polymer-Free Coatings
By Application
•   Coronary Artery Disease
•   Peripheral Artery Disease
By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The market is fragmented into product, application and region. The product segment is bifurcated into polymer-based coatings and polymer free coatings. The polymer-based coatings is categorised into non-biodegradable polymer based and biodegradable polymer based. The polymer free coatings is segregated into micro structured surface, micro porous surface, nano porous surface and slotted tubular surface. The microporous surface segment held the largest drug eluting stents market share during the forecasted timeframe owing to the increased acceptance of DES due to lower rate of in-stent restenosis. The nano porous segment is predicted to lead the market owing to the high drug loading capacity of these products. The application segment is categorised into peripheral artery disease and coronary artery disease. The coronary artery disease segment is anticipated to dominate the market owing to the increased occurrence of appalling diseases like arrhythmia which has boosted the insistence of drug eluting stents over the forecast period.

Regional Analysis:

The North America region expected to dominate the global market, and this can be credited to stringencies in guidelines for medical device approval and manufacturing. Additionally, improved reimbursement coverage along with high rate of incidence of artery diseases has bolstered the proliferation of the market.

Competitive Landscape:

Some of the key market players are Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Biosensors International Group, Biotronik, Lepu Medical Technology, Terumo Medical Corporation, Cook Medical, Shandong JW Medical Systems, Stentys.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global drug eluting stents market by product, by application and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com